Healthcare & Life Sciences
Stayble Therapeutics
Swedenstaybletherapeutics.com
Stayble Therapeutics is a Healthcare & Life Sciences startup based in Sweden, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
1
Investors
About Stayble Therapeutics
Stayble Therapeutics is a company headquartered in Sweden. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Stayble Therapeutics is a clinical-stage pharmaceutical company developing STA363, an injectable treatment for chronic low back pain and leg pain caused by disc degeneration and herniation. The treatment aims to stabilize discs and reduce pain by transforming disc material into connective tissue.
Explore Stayble Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.